Merck (MRK) Return on Capital Employed (2009 - 2026)

Merck has disclosed Return on Capital Employed across 18 years of filings, most recently posting 5.22% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 1083.0% year-over-year to 5.22%; the TTM figure through Mar 2026 stood at 5.22% (down 1083.0% YoY), while the FY2025 annual figure was 4.75%, down 93.0% from the prior year.
• Return on Capital Employed eased to 5.22% in Q1 2026, from 4.47% in the prior quarter.
• Over the last five years, Return on Capital Employed for MRK reached as high as 7.54% in Q3 2025 and fell as low as 17.58% in Q4 2023.
• The 5-year median for Return on Capital Employed is 0.67% (2022), against an average of 2.09%.
• Annual changes were most pronounced in 2023 — Return on Capital Employed tumbled 1642 bps — and 2024, when it soared 2291 bps.
• A 5-year view of Return on Capital Employed shows it stood at 1.15% in 2022, then slumped by 1425 bps to 17.58% in 2023, then jumped by 130 bps to 5.34% in 2024, then decreased by 16 bps to 4.47% in 2025, then tumbled by 217 bps to 5.22% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 5.22%, 4.47%, and 7.54% for Q1 2026, Q4 2025, and Q3 2025 respectively.